Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated : 06/20/2022

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 147 publications

Therapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorders-Experience from Tertiary Care Center in North India.

Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders.

Emerging drugs for the acute treatment of relapses in adult neuromyelitis optica spectrum disorder patients.

Longitudinal extensive transverse myelitis after chemoradiation therapy with durvalumab, a rare complication: case report.

Physiotherapy management of acute transverse myelitis in a pediatric patient in a Nigerian hospital: a case report.

Response to treatment in NMOSD: the Australasian experience.

Inebilizumab for treatment of neuromyelitis optica spectrum disorder in patients with prior rituximab use from the N-MOmentum Study.

Safety and efficacy of rituximab for relapse prevention in myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG)-associated disorders (MOGAD): A systematic review and meta-analysis.

A Missed Case of Area Postrema Syndrome Presenting with Neuromyelitis Optica Spectrum Disorder.

Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United Kingdom.

High cell surface expression and peptide binding affinity of HLA-DQA1*05:03, a susceptible allele of neuromyelitis optica spectrum disorders (NMOSD).

Dysregulated B cell differentiation towards antibody-secreting cells in neuromyelitis optica spectrum disorder.

Showing 1-12 of 147

Last Updated : 06/20/2022